Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB16411 | Camidanlumab tesirine | 1 | Terminated | 1 |
DB09037 | Pembrolizumab | 1 | Terminated | 1 |
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB16411 | Camidanlumab tesirine | 1 | Terminated | 1 |
DB09037 | Pembrolizumab | 1 | Terminated | 1 |